Page 308 - ACCCN's Critical Care Nursing
P. 308

Cardiac Rhythm Assessment and Management  285

             ABLATION                                             studies are well tolerated as long as patients can remain
                                                                  supine for the sometimes extended periods. The applica-
             Ablation therapies are aimed at destroying tissues that (a)   tion of radiofrequency and the consequent tissue injury
             generate  or  sustain  haemodynamically  significant  or   is painless in most cases. 105,106
             potentially lethal arrhythmias (arrhythmic foci or reentry
             pathways),  or  (b)  permit  uncontrollable  atrial  arrhyth-  Success  rates  for  ablation  therapies  have  been  reported
             mias to conduct at rapid rates to the ventricles (the acces-  at  82–92%  for  accessory  pathway  ablation  (depending
             sory pathways of the Wolff–Parkinson–White syndrome,   on  pathway  location),  90–96%  for  AV  nodal  reentry
                                                                                                                 107
             or  at  times  the  AV  node  itself).   Tissue  destruction  is   tachycardia, and 75% for atrial tachycardia and flutter.
                                         106
             achieved by the application of radiofrequency (RF) energy   Complication rates, mostly AV block, have been reported
             to very localised areas of the endocardium, which results   at  2.1–4.4%,  with  procedure-related  mortality  below
             in excessive tissue heating, cellular damage and eventual   0.2%. 106,108   When  applied  to  patients  with  ideopathic
                        106
             tissue death.  Unlike preventive or episode-terminating   ventricular  tachycardia,  procedural  success  has  been
                                                                                     108
             pharmacological  or  electrical  arrhythmia  therapies,     reported at 85–100%.  Complications, including death
                                                                                                  107
             successful  ablation  is  curative  and  can  therefore  spare   from  ventricular  wall  perforation,   have  occurred,
             patients a lifetime of careful medication compliance, self-  but major complication rates of less than 1% are gener-
             monitoring  for  complications,  and  living  under  the   ally seen. 108
             uncertainty  of  arrhythmic  threat  and/or  the  delivery  of   For ablation of ventricular tachycardia, it is necessary to
             therapy from an implantable cardioverter defibrillator.  first perform pace mapping to locate the focus. Endocar-
             The use of percutaneous catheter ablation therapies has   dial  pacing  is  applied  from  many  sites  until  a  paced
             expanded  rapidly  as  technology  and  familiarity  have   rhythm with the same 12-lead ECG morphology as the
             developed, and they have been used to treat atrial, ven-  ventricular  tachycardia  is  achieved.  This  confirms  the
             tricular and AV nodal reentry tachyarrhythmias, as well as   focus,  thus  identifying  the  location(s)  to  which  radio
             the  abnormal  atrioventricular  connections  of  Wolff–  freqency  needs  to  be  applied.  Generally,  ablation  is
             Parkinson–White Syndrome. For incessant atrial fibrilla-  undertaken for monomorphic VT only. 106
             tion, it is sometimes necessary to ablate the AV node to
             control  the  ventricular  rate.  Since  this  causes  complete   SUMMARY
             heart block, a pacemaker must first be implanted. Iden-
             tification of the pulmonary veins as the culprit arrhyth-  Alteration to the heart’s electrophysiological function is
             mic foci for many patients with atrial fibrillation has seen   very common in patients admitted to critical care settings.
             the development of ablation techniques to prevent con-  Arrhythmia detection is largely the responsibility of the
             duction from the pulmonary veins to the atria (pulmo-  critical care nurse, who must maintain accurate monitor-
             nary vein isolation).                                ing, constantly observe for the development of arrhyth-
                                                                  mias, assess their clinical impact, and assist in identifying
             For arrhythmia ablation, electrophysiological studies are   causative factors. The critical care nurse must also deliver
             undertaken to closely map the location of abnormal foci,   the  care  and  management  of  arrhythmias,  including
             reentry circuits or accessory pathways, and radiofrequency   pharmacological and electrical therapies, being aware of
             catheters are then guided to these sites to deliver therapy.   complications  and  management  of  complications  of
             The search for arrhythmic sites may take some time, but   these treatments.




               Case study

               A 63-year-old woman was admitted to intensive care at 12 : 28 on   A unit-based emergency response was activated, including recall
               a  Friday  afternoon  following  Aortic  Valve  Replacement.  Surgery   of the surgeon and anaesthetist, for the following reasons:
               was uneventful, however, post-operative asystole required place-  ●  The patient was known to have underlying asystole. Failure to
               ment  of  two  atrial  and  two  ventricular  epicardial  pacing  wires.    capture, even on a single beat, could progress to complete loss
               Six  minutes  after  admission  the  following  rhythm,  as  seen  in    of capture.
               Figure 11.52, was observed.                        ●  The ventricular output was already at 18 mA and still losing
               ●  Initial pacemaker settings: DDD mode; Rate 80/min; AV delay   capture.  An  adequate  safety  margin  could  not  be  provided,
                  160 ms                                             and there was very little scope for increasing output if failure
               ●  Atrial  output:  20 mA  (maximum)  with  atrial  pulse  width   to capture recurred (maximum output 20 mA on this device).
                  @ 1 ms                                          ●  Atrial  output  was  already  at  maximum  (20 mA)  and  not
               ●  Ventricular output: 18 mA (maximum 20 mA) with ventricular   capturing.
                  pulse width @ 1 ms                              ●  It was Friday afternoon. Ideal resources were available now, but
                                                                     this  would  change  soon,  with  the  resource  limitations  that
               Before continuing, reflect on the following: would you call this a   night duty or weekend staffing pose.
               genuine  emergency;  what  are  the  implications  of  a  single  non-  ●  Simultaneous  atrial  and  ventricular  failure  to  capture  could
               capture  beat  in  this  context;  and  what  steps  you  would  take  to   point to a severe systemic abnormality requiring investigation
               manage the situation?                                 and management.
   303   304   305   306   307   308   309   310   311   312   313